Tumor exosomes block dendritic cells maturation to decrease the T cell immune response

Constantino, 2017, Dendritic cell-based immunotherapy: a basic review and recent advances, Immunol. Res., 65, 798, 10.1007/s12026-017-8931-1 Motta, 2016, Sensitivity of dendritic cells to microenvironment signals, J. Immunol. Res., 2016, 10.1155/2016/4753607 Keirsse, 2017, Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies, J. Leukoc. Biol., 102, 317, 10.1189/jlb.4MR1116-466R Veglia, 2017, Dendritic cells in cancer: the role revisited, Curr. Opin. Immunol., 45, 43, 10.1016/j.coi.2017.01.002 Gardner, 2016, Dendritic cells and cancer immunity, Trends Immunol., 37, 855, 10.1016/j.it.2016.09.006 Gil-Jaramillo, 2016, Dendritic cells a double-edged sword in immune responses during Chagas disease, Front. Microbiol., 7, 1076, 10.3389/fmicb.2016.01076 Kuo, 2014, Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression, Int. J. Cancer, 135, 96, 10.1002/ijc.28673 Tran Janco, 2015, Tumor-infiltrating dendritic cells in cancer pathogenesis, J. Immunol., 194, 2985, 10.4049/jimmunol.1403134 Ning, 2016, beta-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses, Int. J. Cancer, 138, 2713, 10.1002/ijc.30002 Hessvik, 2018, Current knowledge on exosome biogenesis and release, Cell. Mol. Life Sci., 75, 193, 10.1007/s00018-017-2595-9 Liu, 2015, The exosomes in tumor immunity, Oncoimmunology, 4, e1027472, 10.1080/2162402X.2015.1027472 Yu, 2007, Tumor exosomes inhibit differentiation of bone marrow dendritic cells, J. Immunol., 178, 6867, 10.4049/jimmunol.178.11.6867 Xiang, 2009, Induction of myeloid-derived suppressor cells by tumor exosomes, Int. J. Cancer, 124, 2621, 10.1002/ijc.24249 Bastos, 2018, Exosomes in cancer: use them or target them?, Semin. Cell Dev. Diol., 78, 13, 10.1016/j.semcdb.2017.08.009 Robbins, 2014, Regulation of immune responses by extracellular vesicles, Nat. Rev. Immunol., 14, 195, 10.1038/nri3622 Andre, 2002, Malignant effusions and immunogenic tumour-derived exosomes, Lancet, 360, 295, 10.1016/S0140-6736(02)09552-1 Li, 2010, Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer, Clin. Cancer Res., 16, 5153, 10.1158/1078-0432.CCR-10-0820 Qi, 2011, Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived beta-glucans, Blood, 117, 6825, 10.1182/blood-2011-02-339812 Hauser, 2016, Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes, J. Leukoc. Biol., 99, 869, 10.1189/jlb.2MR0815-380R Qi, 2012, Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer, Cancer Immunol. Immunother., 61, 1415, 10.1007/s00262-011-1192-2 Ding, 2015, beta-Glucan enhances cytotoxic T lymphocyte responses by activation of human monocyte-derived dendritic cells via the PI3 K/AKT pathway, Hum. Immunol., 76, 146, 10.1016/j.humimm.2015.01.009 Kuo, 2013, Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway, Carcinogenesis, 34, 2600, 10.1093/carcin/bgt281 Hsu, 2011, Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression, J. Immunol., 187, 1733, 10.4049/jimmunol.1100996 Hurwitz, 2012, Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells, Cancer Immunol. Immunother., 61, 289, 10.1007/s00262-011-1181-5 Andre, 2001, Exosomes in cancer immunotherapy: preclinical data, Adv. Exp. Med. Biol., 495, 349, 10.1007/978-1-4615-0685-0_49 Taylor, 2005, Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects, Br. J. Cancer, 92, 305, 10.1038/sj.bjc.6602316 Whiteside, 2005, Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?, Br. J. Cancer, 92, 209, 10.1038/sj.bjc.6602360 Forster, 1999, CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs, Cell, 99, 23, 10.1016/S0092-8674(00)80059-8 den Haan, 2000, CD8(+) but not CD8(−) dendritic cells cross-prime cytotoxic T cells in vivo, J. Exp. Med., 192, 1685, 10.1084/jem.192.12.1685 Shortman, 2010, The CD8+ dendritic cell subset, Immunol. Rev., 234, 18, 10.1111/j.0105-2896.2009.00870.x Xu, 2007, Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking, J. Immunol., 179, 7577, 10.4049/jimmunol.179.11.7577